Viewing Study NCT06257693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-01-03 @ 6:43 AM
Study NCT ID: NCT06257693
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2023-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Sponsor: Alessa Therapeutics Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EP-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View